ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,906.94
-1.07%
US Tech 100
20,702.00
0.38%
Dow Jones
42,573.73
-0.97%
Brent Oil
74.315
0.29%
Bitcoin
93,885.12
1.32%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSX

  6. Crescita Therapeutics Inc (CTX) Quote

Crescita Therapeutics Inc

Crescita Therapeutics Inc (CTX)

Caltex Australia Limited
0.60
0.00
(0.00%)
Closed December 31 4:12PM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
0.60
Bid
0.57
Ask
0.64
Volume
4,012
0.60 Day's Range 0.60
0.36 52 Week Range 0.69
Market Cap
11.973M
Previous Close
0.60
Open
0.60
Last Trade
182
@
0.6
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
21,663
Shares Outstanding
19,955,000
Dividend Yield
-
PE Ratio
-6.03
Earnings Per Share (EPS)
-0.1
Revenue
17.52M
Net Profit
-1.99M

About Crescita Therapeutics Inc

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.crescitatherapeutics.com
Headquarters
Mississauga, Ontario, Can
Founded
-
Crescita Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the Toronto Stock Exchange with ticker CTX. The last closing price for Crescita Therapeutics was $0.60. Over the last year, Crescita Therapeutics shares have traded in a share price range of $ 0.36 to $ 0.69.

Crescita Therapeutics currently has 19,955,000 shares outstanding. The market capitalization of Crescita Therapeutics is $11.97 million. Crescita Therapeutics has a price to earnings ratio (PE ratio) of -6.03.

Ask ADVFN Intelligence (AI)

CTX Latest News

More News

Crescita Reports Third Quarter 2024 Results

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today reported its financial...

November 06 2024
Business Wire

Crescita Therapeutics Announces Approval of Normal Course Issuer Bid

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced that the...

September 24 2024
Business Wire

Crescita to Present & Participate in 1x1 Meetings at the Planet MicroCap Showcase: VANCOUVER 2024 in Association with Small Cap Discoveries on Thursday, September 26, 2024

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced that it will...

September 12 2024
Business Wire

Crescita Reports Second Quarter 2024 Results

Secures Manufacturing Contract of US$10 Million over 4 Years Completes Strategic Asset Acquisition      Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a...

August 07 2024
Business Wire

Crescita Secures Contract Manufacturing Revenue of $US10 Million Over 4 Years

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house R&D and...

July 22 2024
Business Wire

Leading Canadian Healthcare Services Provider Selects Crescita as Exclusive Manufacturing Partner under 5-Year Agreement

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house R&D and...

July 19 2024
Business Wire

Crescita Expands Medical Aesthetic Portfolio with MicronJetTM600 The World’s Smallest Intradermal Delivery Device

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced that it has...

July 17 2024
Business Wire

Crescita Completes Acquisition of Strategic Assets of Occy Laboratory

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced that it has...

June 26 2024
Business Wire

Crescita to Acquire Strategic Assets of Occy Laboratory

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced that it has...

June 20 2024
Business Wire

Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced the voting...

June 06 2024
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.011.694915254240.590.610.551010390.58169908CS
40.023.448275862070.580.610.54220870.57444285CS
12000.60.640.53216630.5836429CS
260.0815.38461538460.520.690.45213340.58739414CS
520.1122.44897959180.490.690.36169550.5354656CS
156-0.05-7.692307692310.650.830.36159780.59694021CS
260-0.35-36.84210526320.951.010.36196860.66374755CS

CTX - Frequently Asked Questions (FAQ)

What is the current Crescita Therapeutics share price?
The current share price of Crescita Therapeutics is $ 0.60
How many Crescita Therapeutics shares are in issue?
Crescita Therapeutics has 19,955,000 shares in issue
What is the market cap of Crescita Therapeutics?
The market capitalisation of Crescita Therapeutics is CAD 11.97M
What is the 1 year trading range for Crescita Therapeutics share price?
Crescita Therapeutics has traded in the range of $ 0.36 to $ 0.69 during the past year
What is the PE ratio of Crescita Therapeutics?
The price to earnings ratio of Crescita Therapeutics is -6.03
What is the cash to sales ratio of Crescita Therapeutics?
The cash to sales ratio of Crescita Therapeutics is 0.68
What is the reporting currency for Crescita Therapeutics?
Crescita Therapeutics reports financial results in CAD
What is the latest annual turnover for Crescita Therapeutics?
The latest annual turnover of Crescita Therapeutics is CAD 17.52M
What is the latest annual profit for Crescita Therapeutics?
The latest annual profit of Crescita Therapeutics is CAD -1.99M
What is the registered address of Crescita Therapeutics?
The registered address for Crescita Therapeutics is 6733 MISSISSAUGA ROAD, SUITE 800, MISSISSAUGA, ONTARIO, L5N 6J5
What is the Crescita Therapeutics website address?
The website address for Crescita Therapeutics is www.crescitatherapeutics.com
Which industry sector does Crescita Therapeutics operate in?
Crescita Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BSXBelo Sun Mining Corp
$ 0.075
(66.67%)
2.95M
GCUGunnison Copper Corp
$ 0.20
(17.65%)
217.52k
KLSKelso Technologies Inc
$ 0.14
(16.67%)
10.5k
COPRCoppernico Metals Inc
$ 0.255
(13.33%)
60.77k
PPRPrairie Provident Resources Inc
$ 0.045
(12.50%)
979.01k
BABYElse Nutrition Holdings Inc
$ 0.015
(-25.00%)
1.26M
RTGRTG Mining Inc
$ 0.03
(-25.00%)
39.42k
GMTNGold Mountain Mining Corp
$ 0.025
(-16.67%)
391.1k
DBOD Box Technologies Inc
$ 0.135
(-15.63%)
2.34M
LSPKLifeSpeak Inc
$ 0.34
(-15.00%)
3k
CMCanadian Imperial Bank of Commerce
$ 91.07
(0.46%)
8M
TRPTC Energy Corporation
$ 67.04
(0.45%)
7.74M
TTelus Corp
$ 19.30
(-0.82%)
6.27M
ENBEnbridge Inc
$ 60.49
(0.32%)
6.07M
MFCManulife Financial Corporation
$ 44.00
(-0.65%)
5.04M

Discussion

View Full Feed
tw0122 tw0122 34 seconds ago
That's how it's done bear it down merciless first 
BNGO
Here Today Here Today 48 seconds ago
16 million in share dilution incoming!!!! Read the filing. 
RNAZ
maddyandboomer maddyandboomer 1 minute ago
Dilution is awful. If you look at issuance table....it is not for expansion...shares are issued for toxic convertible notes converted by those who slam shares at will into bid (since some don't like term CDer).....and have been doing so for going on 4 years now
AXXA
tw0122 tw0122 3 minutes ago
Bingo .37 
BNGO
dbing dbing 4 minutes ago
So all in all what’s your real take on this stock?
NWBO
maddyandboomer maddyandboomer 5 minutes ago
I just dislike posters making price predictions with zero basis for making such claims....it is called wishful thinking...which is fine but don't give the appearance of being fact based
AXXA
tw0122 tw0122 5 minutes ago
Verastem Oncology Announces FDA Acceptance and Priority Review of New Drug Application for Avutometinib in Combination with Defactinib for the Treatment of Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer
VSTM
tw0122 tw0122 8 minutes ago
4.75
VSTM
sam1933 sam1933 12 minutes ago
Breaking News for #Hedera 🚨
Breaking News for #Hedera 🚨

For the second consecutive month, Hedera has shattered records for both total n
HBARUSD
Chasing Chasing 13 minutes ago
did you figure out all that strong arming in a month
ELTP
lakers17 lakers17 13 minutes ago
I did add a little OTTO as a starter at .0044. Still not clear what they are doing and on X it looks like the bot writes all the posts. Just taking a small, high risk position. That's the crypto game along with many of the large market cap ones I own. I am going all in that the first 6 months of
tw0122 tw0122 16 minutes ago
$1.52
BNAI
gregcod gregcod 16 minutes ago
Great link Trader and Co...IBATs patented absorbent material can refreshed with more added fibers so that the original absorbent material(s) is back to close to original state ..Thus full replacement of the absornent material does not need to be..This is just what I read a whiles back from Burba...
IBATF
tw0122 tw0122 17 minutes ago
1.50 +44% $$$$
MULN
tw0122 tw0122 18 minutes ago
Running 
MULN
knrorrel knrorrel 19 minutes ago
SLRX starts and looks like this stock wants to move higher today.... 🔥🔥🔥🔥🔥🔥🔥
SLRX
TrendTrade2016 TrendTrade2016 20 minutes ago
STEM HERE COMES THE DOLLA
STEM
MasterBlastr MasterBlastr 20 minutes ago
So that means I'm cured, maybe? Kinda feels like it, a little.
knrorrel knrorrel 20 minutes ago
SLRX some add. now , Looks good

SLRX
knrorrel knrorrel 20 minutes ago
SLRX starts and looks like this stock wants to move higher today.... 🔥🔥🔥🔥🔥🔥🔥
SLRX
tw0122 tw0122 20 minutes ago
.24
BHAT
extrinsic55 extrinsic55 23 minutes ago
RIME ask .095 Climbing2ndDayActiveUPwardMove
extrinsic55 extrinsic55 23 minutes ago
RIME ask .095 Climbing2ndDayActiveUPwardMove
extrinsic55 extrinsic55 24 minutes ago
RIME ask .095 Climbing2ndDayActiveUPwardMove
sunspotter sunspotter 24 minutes ago
I doubt that the company IPIX owns any part of BeaMed nowadays.

Of course, there's no way to know as Leo Ehrlich spits on his legal obligations to keep IPIX' shareholders informed.

But over two decades of studying penny stock scams tells me you can be pretty sure that w
IPIX

Your Recent History

TSX
CTX
Crescita Therapeutics
COIN
AWTTUST
AWT
TSX
DBM
Doman Building Materials
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads